Your session is about to expire
← Back to Search
Thermal Therapy
Treatment for Overactive Bladder (REZUM Trial)
N/A
Waitlist Available
Led By Claus Roehrborn, MD
Research Sponsored by Boston Scientific Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
Summary
To evaluate the safety and efficacy of the Rezūm System and assess its effect on urinary symptoms secondary to benign prostatic hyperplasia (BPH).
Eligible Conditions
- Enlarged Prostate
- Overactive Bladder
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Efficacy: Change From Baseline in the International Prostate Symptom Score (IPSS) at 3 Month Follow-Up
Safety: Device Related Serious Complications
Secondary outcome measures
Responders at 12 Months
Responders at 3 Months
Responders at 6 Months
Trial Design
2Treatment groups
Experimental Treatment
Group I: TreatmentExperimental Treatment1 Intervention
Treatment: Rezūm System
Group II: ControlExperimental Treatment1 Intervention
Control: Rigid Cystoscopy
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Rezum System
2013
N/A
~270
Rigid Cystoscopy
2013
N/A
~240
Find a Location
Who is running the clinical trial?
Boston Scientific CorporationLead Sponsor
737 Previous Clinical Trials
854,039 Total Patients Enrolled
Claus Roehrborn, MDPrincipal InvestigatorUT Southwestern
2 Previous Clinical Trials
252 Total Patients Enrolled
Kevin McVary, MDPrincipal InvestigatorSouthern Illinois University
2 Previous Clinical Trials
1,491 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger